GTS Securities’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
GTS Securities's LGND Position: Q3 2026 in Review
GTS Securities opened a new position in Ligand Pharmaceuticals (LGND) in Q3 2026: 651 shares worth $203K. The stake represents ﹤0.01% of the portfolio and ranks #1545 among its holdings.
434 funds tracked by Wall St. Rank hold LGND as of Q3 2026.
- GTS Securities held 651 shares of Ligand Pharmaceuticals worth $203K as of Q3 2026.
- Ligand Pharmaceuticals was a new GTS Securities position in Q3 2026.
- Ligand Pharmaceuticals made up ﹤0.01% of GTS Securities's portfolio in Q3 2026, its #1545 holding.
- 434 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.
Based on GTS Securities's 13F filing for Q3 2026, filed 16 Nov 2026.